151 related articles for article (PubMed ID: 20154435)
1. Relationship of high-molecular-weight adiponectin levels to visceral fat accumulation in hemodialysis patients.
Tamei N; Ogawa T; Ishida H; Ando Y; Nitta K
Intern Med; 2010; 49(4):299-305. PubMed ID: 20154435
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma adiponectin concentration and visceral fat accumulation in hemodialysis patients.
Odamaki M; Furuya R; Kinumura Y; Ikegaya N; Kumagai H
Nephron Clin Pract; 2006; 102(1):c8-13. PubMed ID: 16166803
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin Fractions Influence the Development of Posttransplant Diabetes Mellitus and Cardiovascular Disease in Japanese Renal Transplant Recipients.
Adachi H; Nakayama K; Hayashi N; Matsui Y; Fujimoto K; Yamaya H; Tonami H; Yokoyama H
PLoS One; 2016; 11(10):e0163899. PubMed ID: 27706207
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of metabolic syndrome and pulse wave velocity in hemodialysis patients: diagnosis of obesity by bioelectrical impedance analysis and a novel risk factor for atherosclerosis].
Sasaki N; Takeda S; Saito T; Ando Y; Kusano E
Nihon Jinzo Gakkai Shi; 2009; 51(4):476-83. PubMed ID: 19601557
[TBL] [Abstract][Full Text] [Related]
5. Association of high-molecular-weight to total adiponectin ratio with pulse wave velocity in hemodialysis patients.
Kato A; Odamaki M; Ishida J; Hishida A
Nephron Clin Pract; 2008; 109(1):c18-24. PubMed ID: 18493156
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin and atherosclerosis risk factors in African hemodialysis patients: a population at low risk for atherosclerotic cardiovascular disease.
Amira OC; Naicker S; Manga P; Sliwa K; Mia A; Raal F; Crowther NJ; Immelman RA; Olorunju S
Hemodial Int; 2012 Jan; 16(1):59-68. PubMed ID: 22099423
[TBL] [Abstract][Full Text] [Related]
7. Potential impact of renin-angiotensin system inhibitors and calcium channel blockers on plasma high-molecular-weight adiponectin levels in hemodialysis patients.
Nakagawa N; Yao N; Hirayama T; Ishida M; Ishida H; Wada A; Fujino T; Saijo Y; Kikuchi K; Hasebe N
Hypertens Res; 2011 May; 34(5):592-8. PubMed ID: 21289628
[TBL] [Abstract][Full Text] [Related]
8. High molecular weight adiponectin inhibits vascular calcification in renal allograft recipients.
Nomura-Nakayama K; Adachi H; Miyatake N; Hayashi N; Fujimoto K; Yamaya H; Yokoyama H
PLoS One; 2018; 13(5):e0195066. PubMed ID: 29718962
[TBL] [Abstract][Full Text] [Related]
9. Relationship between abdominal fat accumulation and insulin resistance in hemodialysis patients.
Gohda T; Gotoh H; Tanimoto M; Sato M; Io H; Kaneko K; Hamada C; Tomino Y
Hypertens Res; 2008 Jan; 31(1):83-8. PubMed ID: 18360022
[TBL] [Abstract][Full Text] [Related]
10. Total and HMW adiponectin is independently associated with B-type natriuretic peptide and anemia in chronic hemodialysis patients.
Abe Y; Matsumae T; Eto S; Watanabe M; Ito K; Sasatomi Y; Ogahara S; Nakashima H; Saito T
Intern Med; 2012; 51(23):3247-52. PubMed ID: 23207119
[TBL] [Abstract][Full Text] [Related]
11. Plasma adiponectin levels for prediction of cardiovascular risk among hemodialysis patients.
El-Shafey EM; Shalan M
Ther Apher Dial; 2014 Apr; 18(2):185-92. PubMed ID: 24720410
[TBL] [Abstract][Full Text] [Related]
12. Effects of Aging on Visceral and Subcutaneous Fat Areas and on Homeostasis Model Assessment of Insulin Resistance and Insulin Secretion Capacity in a Comprehensive Health Checkup.
Hirose H; Takayama M; Iwao Y; Kawabe H
J Atheroscler Thromb; 2016; 23(2):207-15. PubMed ID: 26412583
[TBL] [Abstract][Full Text] [Related]
13. Differences in the pathology of the metabolic syndrome with or without visceral fat accumulation: a study in pre-diabetic Japanese middle-aged men.
Mori Y; Hoshino K; Yokota K; Itoh Y; Tajima N
Endocrine; 2006 Feb; 29(1):149-53. PubMed ID: 16622304
[TBL] [Abstract][Full Text] [Related]
14. Association of subcutaneous and visceral fat mass with serum concentrations of adipokines in subjects with type 2 diabetes mellitus.
Saito T; Murata M; Otani T; Tamemoto H; Kawakami M; Ishikawa SE
Endocr J; 2012; 59(1):39-45. PubMed ID: 22019947
[TBL] [Abstract][Full Text] [Related]
15. Adiponectin and cardiovascular outcomes among hemodialysis patients.
Abdallah E; Waked E; Nabil M; El-Bendary O
Kidney Blood Press Res; 2012; 35(4):247-53. PubMed ID: 22286012
[TBL] [Abstract][Full Text] [Related]
16. [Plasma levels of adiponectin and tumor necrosis factor-alpha in children with obesity].
Yan WJ; Wu J; Mo J; Huang CW; Peng LW; Xu L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):47-50. PubMed ID: 19149923
[TBL] [Abstract][Full Text] [Related]
17. Association of serum adiponectin levels with all-cause mortality in hemodialysis patients.
Ohashi N; Kato A; Misaki T; Sakakima M; Fujigaki Y; Yamamoto T; Hishida A
Intern Med; 2008; 47(6):485-91. PubMed ID: 18344634
[TBL] [Abstract][Full Text] [Related]
18. Total and high molecular weight but not trimeric or hexameric forms of adiponectin correlate with markers of the metabolic syndrome and liver injury in Thai subjects.
Liu Y; Retnakaran R; Hanley A; Tungtrongchitr R; Shaw C; Sweeney G
J Clin Endocrinol Metab; 2007 Nov; 92(11):4313-8. PubMed ID: 17698903
[TBL] [Abstract][Full Text] [Related]
19. Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.
Rhee CM; Nguyen DV; Moradi H; Brunelli SM; Dukkipati R; Jing J; Nakata T; Kovesdy CP; Brent GA; Kalantar-Zadeh K
Am J Kidney Dis; 2015 Aug; 66(2):313-21. PubMed ID: 25824125
[TBL] [Abstract][Full Text] [Related]
20. Circulating CTRP9 correlates with the prevention of aortic calcification in renal allograft recipients.
Miyatake N; Adachi H; Nomura-Nakayama K; Okada K; Okino K; Hayashi N; Fujimoto K; Furuichi K; Yokoyama H
PLoS One; 2020; 15(1):e0226526. PubMed ID: 31945100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
